Without this deletion, TP53 mutations in IDH-mut astrocytomas correlate with reduced survival compared to TP53-wildtype [24], underscoring the role of tumor-suppressor genes in cancer progression. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).